Prognostic Scoring System for Mortality of Hospitalized COVID-19 Patients in Resource-Limited Settings: A Multicenter Study from COVID-19 Referral Hospitals

Siti Rizny F. Saldi, Eka Dian Safitri, Siti Setiati, Respati W Ranakusuma, Jessica Marsigit, Muhammad K Azwar, Puji Astuti, Cut Yulia Indah Sari, Rahmi Istanti, Mira Yulianti, Cleopas Martin Rumende, Evy Yunihastuti, Adityo Susilo, Kuntjoro Harimurti, Lies Dina Liastuti, Trimartani Trimartani, Ratna Dwi Restuti, Ari Fahrial Syam

Abstract


Background: Many studies identified the risk factors and prognostic factors related to in-hospital COVID-19 mortality using sophisticated laboratory tests. Cost and the availability of supporting blood tests may be problematic in resource-limited settings. This multicenter cohort study was conducted to assess the factors associated with mortality of COVID-19 patients aged 18 years and older, based on history taking, physical examination, and simple blood tests to be used in resource-limited settings. Methods: The study was conducted between July 2020 and January 2021 in five COVID-19 referral hospitals in Indonesia. Among 1048 confirmed cases of COVID-19, 160 (15%) died during hospitalization. Results: Multivariate analysis showed eight predictors of in-hospital mortality, namely increased age, chronic kidney disease, chronic obstructive pulmonary disease, fatigue, dyspnea, altered mental status, neutrophil-lymphocyte ratio (NLR) ≥ 5.8, and severe-critical condition. This scoring system had an Area-under-the-curve (AUC) of 84.7%. With cut-off score of 6, the sensitivity was 76.3% and the specificity was 78.2%. Conclusion: The result of this practical prognostic scoring system may be a guide to decision making of physicians and help in the education of family members related to the possible outcome.

Keywords


COVID-19; prognostic; predictive score; mortality; resource-limited settings

References


Centers for Disease Control and Prevention. 2019 Novel Coronavirus, Wuhan, China, https://www.cdc.gov/coronavirus/2019-ncov/about/index.html. (2020, accessed 17 June 2021).

Mostaza JM, García-Iglesias F, González-Alegre T, et al. Clinical course and prognostic factors of COVID-19 infection in an elderly hospitalized population. Arch Gerontol Geriatr. 2020;91:104204.

Gupta RK, Marks M, Samuels THA, et al. Systematic evaluation and external validation of 22 prognostic models among hospitalised adults with COVID-19: An observational cohort study. Eur Respir J. 2020; 56. Epub ahead of print 1 December 2020. DOI: 10.1183/13993003.03498-2020.

Gue YX, Tennyson M, Gao J, et al. Development of a novel risk score to predict mortality in patients admitted to hospital with COVID-19. Sci Rep. 2020; 10:21379.

Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020;584:430–6.

Johns Hopkins Coronavirus Resource Center. Mortality Analyses, https://coronavirus.jhu.edu/data/mortality (2021, accessed 25 August 2021).

Setiati S, Azwar MK. COVID-19 and Indonesia. Acta Med Indones. 2020;52:84–9.

Knight SR, Ho A, Pius R, et al. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score. BMJ. 2020;m3339.

Grobbee D, Hoes A. Clinical Epidemiology: Principles, Methods, and Applications for Clinical Research. 2nd ed. Burlington, MA: Jones & Bartlett Learning; 2014.

Collins GS, Reitsma JB, Altman DG, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ. 2015;350:g7594.

World Health Organization. WHO Information Notice for IVD Users 2020/05, https://www.who.int/news/item/20-01-2021-who-information-notice-for-ivd-users-2020-05 (2021, accessed 5 March 2021).

World Health Organization. Clinical management of COVID-19: living guidance, https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-1 (2021).

Song C, Xu J, He J, et al. COVID-19 early warning score: a multi-parameter screening tool to identify highly suspected patients. medRxiv Prepr. Epub ahead of print 2020. DOI: 10.1101/2020.03.05.20031906.

Bradley P, Frost F, Tharmaratnam K, et al. Utility of established prognostic scores in COVID-19 hospital admissions: multicentre prospective evaluation of CURB-65, NEWS2 and qSOFA. BMJ Open Respir Res. 2020;7:e000729.

Booth A, Reed AB, Ponzo S, et al. Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis. PLoS One. 2021;16:e0247461.

Franceschi C, Garagnani P, Parini P, et al. Inflammaging: a new immune–metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018;14:576–90.

Azwar MK, Setiati S, Rizka A, et al. Clinical Profile of Elderly Patients with COVID-19 hospitalised in Indonesia’s National General Hospital. Acta Med Indones. 2020;52:199–205.

Pakhchanian H, Raiker R, Mukherjee A, et al. Outcomes of COVID-19 in CKD Patients. Clin J Am Soc Nephrol. 2021;CJN.13820820.

Podestà MA, Valli F, Galassi A, et al. COVID-19 in Chronic Kidney Disease: The Impact of Old and Novel Cardiovascular Risk Factors. Blood Purif. 2021;1–10.

Leung JM, Niikura M, Yang CWT, et al. COVID-19 and COPD. Eur Respir J. 2020;56:2002108.

Lee SC, Son KJ, Han CH, et al. Impact of COPD on COVID-19 prognosis: A nationwide population-based study in South Korea. Sci Rep. 2021;11:3735.

He X, Cheng X, Feng X, et al. Clinical Symptom Differences Between Mild and Severe COVID-19 Patients in China: A Meta-Analysis. Front Public Health; 8. Epub ahead of print 14 January 2021. DOI: 10.3389/fpubh.2020.561264.

Yang L, Jin J, Luo W, et al. Risk factors for predicting mortality of COVID-19 patients: A systematic review and meta-analysis. PLoS One. 2020;15:e0243124.

Rudroff T, Fietsam AC, Deters JR, et al. Post-COVID-19 fatigue: Potential contributing factors. Brain Sci. 2020;10:1012.

Kenerly MJ, Shah P, Patel H, et al. Altered mental status is an independent predictor of mortality in hospitalized COVID-19 patients. Irish J Med Sci. 2021;1971. Epub ahead of print 10 February 2021. DOI: 10.1007/s11845-021-02515-4.

Pezzini A, Padovani A. Lifting the mask on neurological manifestations of COVID-19. Nat Rev Neurol. 2020; 16:636–44.

Simadibrata DM, Calvin J, Wijaya AD, et al. Neutrophil-to-lymphocyte ratio on admission to predict the severity and mortality of COVID-19 patients: A meta-analysis. Am J Emerg Med. 2021;42:60–9.

Li X, Liu C, Mao Z, et al. Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis. Crit Care. 2020;24:647.

Torres Acosta MA, Singer BD. Pathogenesis of COVID-19-induced ARDS: implications for an ageing population. Eur Respir J. 2020;56:2002049.

Hojyo S, Uchida M, Tanaka K, et al. How COVID-19 induces cytokine storm with high mortality. Inflamm Regen. 2020;40:37.

Mei Q, Wang AY, Bryant A, et al. Development and validation of prognostic model for predicting mortality of COVID-19 patients in Wuhan, China. Sci Rep. 2020;10:1–12.


Full Text: PDF

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.